Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Regorafenib in Adults 70 Years or Older With Metastatic Colorectal Cancer: A Phase II Study

NCT02466009 is registered in ClinicalTrials.gov with University of Rochester as lead sponsor.

NCT NCT02466009
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02466009 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Regorafenib in Adults 70 Years or Older With Metastatic Colorectal Cancer: A Phase II Study
Lead sponsor
University of Rochester
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2015
Completion date
March 9, 2022
Enrollment
27 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic colorectal cancer